Evidence map›Paper›PMID 36814553›Full record

ArticleERJ open research2023

Unravelling young COPD and pre-COPD in the general population.

Borja G Cosío, Ciro Casanova, Juan José Soler-Cataluña, Joan B Soriano, Francisco García-Río, Pilar de Lucas, Inmaculada Alfageme, José Miguel Rodríguez González-Moro, Guadalupe Sánchez, Julio Ancochea and 1 more

Open access · goldAbstract read
In one paragraph

Article in ERJ open research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Small Airway Disease in Pre-COPD and Early COPD: Insights Into the Pulmonary "Silent Zone".International journal of chronic obstructive pulmonary disease · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Towards early detection and disease interception of COPD across the lifespan.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Borja G CosíoDepartment of Medicine, University of Balearic Islands, Palma, Spain.ORCID https://orcid.org/0000-0002-6388-8209
Ciro CasanovaServicio de Neumología, Hospital Universitario Nuestra Señora de Candelaria, Tenerife, Spain.
Juan José Soler-CataluñaCIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Joan B SorianoCIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.ORCID https://orcid.org/0000-0001-9740-2994
Francisco García-RíoCIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.ORCID https://orcid.org/0000-0002-7227-2238
Pilar de LucasServicio de Neumología, Hospital General Gregorio Marañon, Madrid, Spain.
Inmaculada AlfagemeUnidad de Gestión Clínica de Neumología, Hospital Universitario Virgen de Valme, Universidad de Sevilla, Seville, Spain.
José Miguel Rodríguez González-MoroServicio de Neumología, Hospital Universitario "Príncipe de Asturias", Universidad de Alcalá, Alcalá de Henares, Spain.ORCID https://orcid.org/0000-0002-8446-3373
Guadalupe SánchezDepartamento Médico, GSK, Tres Cantos, Spain.ORCID https://orcid.org/0000-0003-4352-3509
Julio AncocheaCIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Marc MiravitllesCIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.ORCID https://orcid.org/0000-0002-9850-9520
Instituto de Salud Carlos III · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario de Valme · ESHospital Universitario La Paz · ESHospital Universitario Nuestra Señora de Candelaria · ESUniversidad de Alcalá · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is commonly diagnosed when the airflow limitation is well established and symptomatic. We aimed to identify individuals at risk of developing COPD according to the concept of pre-COPD and compare their clinical characteristics with 1) those who have developed the disease at a young age, and 2) the overall population with and without COPD. Methods: The EPISCAN II study is a cross-sectional, population-based study that aims to investigate the prevalence of COPD in Spain in subjects ≥40 years of age. Pre-COPD was defined as the presence of emphysema >5% and/or bronchial thickening by computed chromatography (CT) scan and/or diffusing capacity of the lung for carbon monoxide ( Results: Among the 1077 individuals with FEV Conclusions: 22.3% of the studied population was at risk of developing COPD, with similar symptomatic and structural changes to those with well-established disease without airflow obstruction. This COPD at-risk population is different from those that develop COPD at a young age.

Identifiers

PMID36814553
PMCPMC9940715
OpenAlexW4304974791

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.